These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1510407)

  • 21. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure to sub-inhibitory concentrations of gentamicin, ciprofloxacin and cefotaxime induces multidrug resistance and reactive oxygen species generation in meticillin-sensitive Staphylococcus aureus.
    Bhattacharya G; Dey D; Das S; Banerjee A
    J Med Microbiol; 2017 Jun; 66(6):762-769. PubMed ID: 28598307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of sub-mics of selected antibiotics on hydrophobic and adhering properties of Klebsiella pneumoniae strains isolated from urine samples].
    Sekowska A; Gospodarek E; Wróblewska J
    Med Dosw Mikrobiol; 2008; 60(4):297-302. PubMed ID: 19382601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Cefotaxime- and Ciprofloxacin-Resistant Commensal Escherichia coli Originating from Belgian Farm Animals Indicates High Antibiotic Resistance Transfer Rates.
    Lambrecht E; Van Meervenne E; Boon N; Van de Wiele T; Wattiau P; Herman L; Heyndrickx M; Van Coillie E
    Microb Drug Resist; 2018; 24(6):707-717. PubMed ID: 29148895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial Clustering of Escherichia coli with Reduced Susceptibility to Cefotaxime and Ciprofloxacin among Dairy Cattle Farms Relative to European Starling Night Roosts.
    Medhanie GA; Pearl DL; McEwen SA; Guerin MT; Jardine CM; Schrock J; LeJeune JT
    Zoonoses Public Health; 2017 May; 64(3):204-212. PubMed ID: 27460156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin.
    Gould IM; Milne K; Jason C
    Drugs Exp Clin Res; 1990; 16(12):621-8. PubMed ID: 2130004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of ciprofloxacin against resistant clinical isolates.
    Kelley SG; Bertram MA; Young LS
    J Antimicrob Chemother; 1986 Mar; 17(3):281-6. PubMed ID: 2939048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility and the in vitro postantibiotic effects of vancomycin and ciprofloxacin against Bacillus cereus isolates.
    Godič Torkar K; Bedenić B; Plečko V
    J Chemother; 2016 Jun; 28(3):151-8. PubMed ID: 26358183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
    Zhanel GG; Crampton J; Kim S; Nicolle LE; Davidson RJ; Hoban DJ
    Chemotherapy; 1992; 38(6):388-94. PubMed ID: 1288962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
    Chalkley LJ; Koornhof HJ
    Antimicrob Agents Chemother; 1985 Aug; 28(2):331-42. PubMed ID: 2939797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentially-growing E. coli cells by means of flow cytometry.
    Walberg M; Gaustad P; Steen HB
    Cytometry; 1997 Feb; 27(2):169-78. PubMed ID: 9012384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of gentamicin and ciprofloxacin against Gram-negative bacteria: interactions with pig and calf sera.
    Miglioli PA; Silini R; Carzeri O; Grabocka E; Allerberger F
    Pharmacol Res; 1999 Apr; 39(4):321-3. PubMed ID: 10208763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
    Saionji K
    Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
    Ko WC; Chiang SR; Lee HC; Tang HJ; Wang YY; Chuang YC
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2217-22. PubMed ID: 12821471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity.
    Guan L; Burnham JC
    J Antimicrob Chemother; 1992 May; 29(5):529-38. PubMed ID: 1320604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.
    Fuentes F; Izquierdo J; Martín MM; Gomez-Lus ML; Prieto J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):414-8. PubMed ID: 9527796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.